Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Carroll

Showing results (541-550 of 573) with videos related to

Pageof 58
Sort By:
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Plos Pathogens|October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVACRobert W Cross, Ira M Longini, Stephan Becker, et al.
Nature Structural & Molecular Biology|August 2, 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientDaming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Cell|March 17, 2021
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced seraDaming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, et al.
Nature Medicine|May 7, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesJordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature Communications|January 23, 2021
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responsesTiong Kit Tan, Pramila Rijal, Rolle Rahikainen, et al.
Cell|March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraPiyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Nature Medicine|December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesJordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Pageof 58

Showing results (541-550 of 573) with videos related to

Sort By:
Pageof 58
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Plos Pathogens|October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVACRobert W Cross, Ira M Longini, Stephan Becker, et al.
Nature Structural & Molecular Biology|August 2, 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientDaming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Cell|March 17, 2021
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced seraDaming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, et al.
Nature Medicine|May 7, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesJordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature Communications|January 23, 2021
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responsesTiong Kit Tan, Pramila Rijal, Rolle Rahikainen, et al.
Cell|March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraPiyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Nature Medicine|December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesJordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Pageof 58